Risk.net

Direxion continues leveraged trend with real estate ETFs

Direxion has launched two new exchange-traded funds (ETFs) which give three times leveraged exposure to the MSCI US Real Estate Index. The Direxion Daily Real Estate Bull 3x Shares offers 300% of the daily upside performance of the index, whereas the Real Estate Bear offers 300% of the downside.

    • Sophia Morrell
  • LinkedIn  
  • Save this article
  • Print this page  

The funds have been listed on the Arca platform of the New York Stock Exchange (NYSE). Long and short leveraged funds have recently come under fire following revelations that while the products closely track daily index performance, longer term fund and index performance can be widely deviated.

Subsequently, NYSE warns investors that the compounding of daily returns means that any returns for periods longer than one day are likely to differ from the stated target, and advises that holdings

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Copyright Infopro Digital Limited. All rights reserved.

As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.

If you would like to purchase additional rights please email info@risk.net

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.

If you would like to purchase additional rights please email info@risk.net

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

More on Exchange-traded products

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here